Repeats [Study As­sess­ment]

posted by ElMaestro  – Denmark, 2013-07-27 14:27 (4307 d 10:30 ago) – Posting: # 11072
Views: 20,713

Hi Sam,

❝ One last suggestions I need from your end, if we go to repeat the whole study without any solid reason except the unexpected PE compared to the pilot study. What will be regulatory queries consequence with the regulatory approval. Will they approve our products based on the new data if it qualifies after repeat.


I don't know how they will react. If you have a PE of 0.79 in one pivotal trial and the next trial passes with flying colors and PE close to 1.00 then I think an eyebrow might be raised here and there.

Pass or fail!
ElMaestro

Complete thread:

UA Flag
Activity
 Admin contact
23,424 posts in 4,927 threads, 1,670 registered users;
111 visitors (0 registered, 111 guests [including 66 identified bots]).
Forum time: 00:57 CEST (Europe/Vienna)

If you shut your door to all errors
truth will be shut out.    Rabindranath Tagore

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5